Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • colaneri
    Member
    • Jul 2012
    • 30

    #1

    differentially methylated sites with methylKit

    I want to generate an outfile containing or C site (CG, CHG or CHH) that are differentially methylated (DM) using the R package methylKit

    The problem is that I got a file that is empty.

    I understand that outfiles listing hypermethylated or Hypomethylated can be empty simply because there are not DM sites between the compared samples. However I'm sure this is not the case and please let me explain before go to my question.

    I have 4 samples ( control vs treatment with 2 replicates each). If I compare tiles of 100 bp with a step.size of 50 I get a bunch of DMRs. However if I try to found difference with single base resolution I got nothing. This do not have sense to me and I suspect I'm doing something wrong during the analysis. I willl appreciate if someone can read the commands i used and help me to identify my error.

    #### Methyl seq sample detail
    SAMPLE

    C4_ctrl BC1 REP1 control
    C7_ctrl BC5 REP2 control

    C4_PEG BC3 REP1 treatment
    C7_PEG BC7 REP2 treatment



    ### In this example I'm comparing control=ctrl samples against the
    ## treatment=PEG in any context (CG, CHG, CHH) from; chr1
    > library(methylKit);
    > library(graphics);
    > comparisonName="C_ctrl_vs_C_PEG_anyContext_site_by_site";ou
    > chrom="chr1";
    > C4_ctrl="BC1"; C7_ctrl="BC5";
    > C4_PEG="BC3"; C7_PEG="BC7";
    > ctrl1=paste(C4_ctrl, chrom, "MethylKit.inputdata.anyContext.txt", sep=".");
    > ctrl2=paste(C7_ctrl, chrom, "MethylKit.inputdata.anyContext.txt", sep=".");
    >PEG1=paste(C4_PEG, chrom, "MethylKit.inputdata.anyContext.txt", sep=".");
    >PEG2=paste(C7_PEG, chrom, "MethylKit.inputdata.anyContext.txt", sep=".");
    > file.list <- list(ctrl1,ctrl2,PEG1,PEG2);
    > myobj <- read(file.list, sample.id = list(ctrl1,ctrl2,PEG1,PEG2), assembly="TAIR10", treatment=c(1,1,0,0), context="anyContext");
    filtered.myobj=filterByCoverage(myobj,lo.count=10,lo.perc=NULL,hi.count=NULL,hi.perc=99.9)
    >meth <- unite(myobj, destrand = FALSE);
    >myDiff <- calculateDiffMeth(meth, num.cores=4);

    #filtering for significant differential methylation
    > myDiff.hyper <- get.methylDiff(myDiff, difference = 10, qvalue = 0.01, type = "hyper");
    > myDiff.hypo <- get.methylDiff(myDiff, difference = 10, qvalue = 0.01, type = "hypo");

    #output data for hypermethylated, hypomethylated, and all tiles

    > outfile1 = paste(comparisonName, chrom, "hyper", "txt", sep=".");
    write.table(as.data.frame(myDiff.hyper), file=outfile1, sep="\t", col.names=TRUE, row.names=FALSE);
    > outfile2 = paste(comparisonName, chrom, "hypo", "txt", sep=".");
    write.table(as.data.frame(myDiff.hypo), file=outfile2, sep="\t", col.names=TRUE, row.names=FALSE);
    > outfile3 = paste(comparisonName, chrom, "united", "txt", sep=".");
    write.table(as.data.frame(meth), file=outfile3, sep="\t", col.names=TRUE, row.names=FALSE);

    ###the result is that outfile 1 and outfile2 are empty.. What I did wrong?

    ###I will appreciate any help

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 08-13-2026, 12:22 PM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-11-2026, 10:35 AM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-06-2026, 07:41 AM
0 responses
32 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-03-2026, 10:13 AM
0 responses
50 views
0 reactions
Last Post SEQadmin2  
Working...